72 related articles for article (PubMed ID: 16429964)
1. Case study: an active, 24-year-old woman positive for HIV.
JAAPA; 2006 Jan; Suppl():14. PubMed ID: 16429964
[No Abstract] [Full Text] [Related]
2. Clinical decisions. Preexposure prophylaxis for HIV prevention.
Abdool Karim SS; Gray GE; Martinson N
N Engl J Med; 2012 Aug; 367(5):462-5. PubMed ID: 22784042
[No Abstract] [Full Text] [Related]
3. European CHMP issues positive opinion for Atripla.
AIDS Patient Care STDS; 2007 Nov; 21(11):890. PubMed ID: 18338431
[No Abstract] [Full Text] [Related]
4. Antiretroviral therapy alone resulted in successful resolution of large idiopathic esophageal ulcers in a patient with acute retroviral syndrome.
Nishijima T; Tsukada K; Nagata N; Watanabe K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
AIDS; 2011 Aug; 25(13):1677-9. PubMed ID: 21811107
[No Abstract] [Full Text] [Related]
5. 96-week CASTLE data show similar efficacy results.
AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
[No Abstract] [Full Text] [Related]
6. FDA notifications. Updated Atripla label approved.
AIDS Alert; 2010 Mar; 25(3):36. PubMed ID: 20629262
[No Abstract] [Full Text] [Related]
7. Study shows people can safely switch to Atripla.
Proj Inf Perspect; 2008 Dec; (47):2. PubMed ID: 19226673
[No Abstract] [Full Text] [Related]
8. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
9. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
10. Immune reconstitution renal-limited sarcoidosis presenting as acute kidney injury.
Fernandez VA; Thomas DB; Reiser IW; Spitalewitz S
Int J STD AIDS; 2012 Jan; 23(1):68-70. PubMed ID: 22362697
[TBL] [Abstract][Full Text] [Related]
11. The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
Chetchotisakd P
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):801-5. PubMed ID: 19735222
[TBL] [Abstract][Full Text] [Related]
12. Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey.
Delaugerre C; Marcelin AG; Soulié C; Chaix ML; Katlama C; Girard PM; Calvez V; Morand-Joubert L
AIDS; 2007 Jun; 21(10):1365-7. PubMed ID: 17545716
[TBL] [Abstract][Full Text] [Related]
13. Vaccine briefs.
McEnery R; Kresge KJ
IAVI Rep; 2010; 14(6):18-9. PubMed ID: 21384772
[No Abstract] [Full Text] [Related]
14. [Complete HAART in a single pill. New milestone for improving compliance].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():40-1. PubMed ID: 19024916
[No Abstract] [Full Text] [Related]
15. [One pill--all HAART. Complete divergent HAART in a single tablet per day].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():76-7. PubMed ID: 19024926
[No Abstract] [Full Text] [Related]
16. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
17. Oral preexposure prophylaxis for HIV--another arrow in the quiver?
Michael NL
N Engl J Med; 2010 Dec; 363(27):2663-5. PubMed ID: 21091280
[No Abstract] [Full Text] [Related]
18. Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
Jenny-Avital ER
N Engl J Med; 2006 Jun; 354(23):2506-8; author reply 2506-8. PubMed ID: 16764056
[No Abstract] [Full Text] [Related]
19. Rationing antiretroviral therapy in Africa--treating too few, too late.
Ford N; Mills E; Calmy A
N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
[No Abstract] [Full Text] [Related]
20. Tapping into combination pills for HIV.
Hughes B
Nat Rev Drug Discov; 2009 Jun; 8(6):439-40. PubMed ID: 19483700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
